Advanced Enzyme Technologies バランスシートの健全性
財務の健全性 基準チェック /66
Advanced Enzyme Technologiesの総株主資本は₹13.9B 、総負債は₹256.9Mで、負債比率は1.8%となります。総資産と総負債はそれぞれ₹15.5Bと₹1.6Bです。 Advanced Enzyme Technologiesの EBIT は₹1.7Bで、利息カバレッジ比率-16.8です。現金および短期投資は₹5.1Bです。
主要情報
1.8%
負債資本比率
₹256.89m
負債
| インタレスト・カバレッジ・レシオ | -16.8x |
| 現金 | ₹5.07b |
| エクイティ | ₹13.89b |
| 負債合計 | ₹1.60b |
| 総資産 | ₹15.49b |
財務の健全性に関する最新情報
更新なし
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21財務状況分析
短期負債: ADVENZYMESの 短期資産 ( ₹8.1B ) が 短期負債 ( ₹1.0B ) を超えています。
長期負債: ADVENZYMESの短期資産 ( ₹8.1B ) が 長期負債 ( ₹564.4M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ADVENZYMES総負債よりも多くの現金を保有しています。
負債の削減: ADVENZYMESの負債対資本比率は、過去 5 年間で2.5%から1.8%に減少しました。
債務返済能力: ADVENZYMESの負債は 営業キャッシュフロー によって 十分にカバー されています ( 553.6% )。
インタレストカバレッジ: ADVENZYMES支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。